Home » Plexxikon, Roche Sign Deal to Develop, Commercialize Kinase Inhibitor
Plexxikon, Roche Sign Deal to Develop, Commercialize Kinase Inhibitor
Plexxikon Inc. and Roche jointly announced that they have entered into an agreement to develop and commercialize a second novel kinase inhibitor, PLX5568.
RTTNews
RTTNews
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May